rosie perez & chris rock express opinion on the

alernative treatments availsble for a woman with lupus


1 andrew cuomo style


2 uspto.gov inventir search faustmsn


and you thought they were only a couple of masked comic book charscters eho vould not read or write

Benefits of BCG-induced Metabolic Switch From Oxidative Phosphorylation to Aerobic Glycolysis in Autoimmune and Nervous System Diseases

D L Faustman 1

Affiliations 

• PMID: 32107806
 
• DOI: 10.1111/joim.13050

Abstract

The most commonly used vaccine worldwide, bacillus Calmette-Guérin (BCG), appears to have the ability to restore blood sugar control in humans with early onset but long-duration type 1 diabetes when a repeat vaccination strategy is used. This is a process that may be driven by a metabolic switch from overactive oxidative phosphorylation to accelerated aerobic glycolysis and a reset of the immune system. BCG is a live, attenuated strain of Mycobacteria bovis, a cousin of M. tuberculosis. Humans and Mycobacteria, which are found in the environment and in warm-blooded hosts, share a long coevolutionary history. In recent times, humans have had fewer exposures to these and other microorganisms that historically helped shape the immune response. By 're-introducing' an attenuated form of Mycobacteria via BCG vaccination, humans might benefit from an immunological perspective, a concept supported by a growing body of data in autoimmunity and robust data on the nonspecific immune effects of BCG related to protection from diverse infections and early mortality. New findings of immune and metabolic defects in type 1 diabetes that can be corrected with repeat BCG vaccination suggest that this therapeutic strategy may be applicable in other diseases with inadequate aerobic glycolysis, including Parkinson's disease, dementia, depression and other disorders affecting the nervous system.

Keywords: BCG vaccine; aerobic glycolysis; autoimmunity; diabetes mellitus; mycobacterium; nervous system diseases; type 1.